An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging
Advanced Science · 2023
DOI: 10.1002/advs.202207066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Mangmang Sang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Diseases, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, No. 2999 Jinshan Ro…. Hauptthemen laut MEDLINE: Atherosclerosis, Plaque, Atherosclerotic. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Xiamen Natural Science Foundation Youth Program.
Abstract (Originalsprache)
Developing activatable fluorescent probes with superlative fluorescence enhancement factor ( F / F 0 ) to improve the signal‐to‐noise (S/N) ratio is still an urgent issue. “AND” molecular logic gates are emerging as a useful tool for enhanced probes selectivity and accuracy. Here, an “AND” logic gate is developed as super‐enhancers for designing activatable probes with huge F / F 0 and S/N ratio. It utilizes lipid‐droplets (LDs) as controllable background input and sets the target analyte as variable input. The fluorescence is tremendously quenching due to double locking, thus an extreme F / F 0 ratio of target analyte is obtained. Importantly, this probe can transfer to LDs after a response occurs. The target analyte can be directly visualized through the spatial location without a control group. Accordingly, a peroxynitrite (ONOO − ) activatable probe (CNP2‐B) is de novo designed. The F / F 0 of CNP2‐B achieves 2600 after reacting with ONOO − . Furthermore, CNP2‐B can transfer from mitochondria to lipid droplets after being activated. The higher selectivity and S/N ratio of CNP2‐B are obtained than commercial probe 3'‐(p‐hydroxyphenyl) fluorescein (HPFin vitro and in vivo. Therefore, the atherosclerotic plaques at mouse models are delineated clearly after administration with in situ CNP2‐B probe gel. Such input controllable “AND” logic gate is envisioned to execute more imaging tasks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cardiovascular Diseases, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, No. 2999 Jinshan Road, Huli District, Xiamen, 361006, China.
- Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, No. 157, Daming Road, Qinhuai District, Nanjing, 210000, China.
- School of Pharmacy, Gannan Medical University, No. 1 Medical College Road, Zhanggong District, Ganzhou, 341000, China.
- Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen People's Hospital, Southern University of Science and Technology, 3046 Shennan East Road, Luohu District, Shenzhen, 518055, China.
ORCID-Profile: Jinrong Zheng
Förderung
- National Natural Science Foundation of China
- Xiamen Natural Science Foundation Youth Program
Zitieren
APA
Sang, M., Huang, Y., Wang, L., Chen, L., Nawsherwan, Li, G., Wang, Y., Yu, X., Dai, C., & Zheng, J. (2023). An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging. Advanced Science. https://doi.org/10.1002/advs.202207066
Vancouver
Sang M, Huang Y, Wang L, Chen L, Nawsherwan, Li G, et al. An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging. Advanced Science. 2023. doi:10.1002/advs.202207066
BibTeX
@article{Sang2023,
author = {Sang, Mangmang and Huang, Yibo and Wang, Lu and Chen, Lei and Nawsherwan and Li, Gang and Wang, Yan and Yu, Xiu and Dai, Cuilian and Zheng, Jinrong},
title = {An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202207066}
}
EUVIMED